Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rabinowitz

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|March 24, 2004
Correlates of cognitive deficits in first episode schizophreniaGitry Heydebrand, Marc Weiser, Jonathan Rabinowitz, et al.
The American Journal of Psychiatry|November 27, 2002
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorderAbraham Reichenberg, Mark Weiser, Jonathan Rabinowitz, et al.
Neurology|September 8, 2019
Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trialLon S Schneider, Yona Geffen, Jonathan Rabinowitz, et al.
Schizophrenia Research|November 25, 2003
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episodeAsaf Caspi, Abraham Reichenberg, Mark Weiser, et al.
Schizophrenia Bulletin|May 23, 2008
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disordersAbraham Reichenberg, Philip D Harvey, Christopher R Bowie, et al.
Early Intervention in Psychiatry|January 17, 2020
Early predictors of mental health in mid-adulthoodLisa J Pijnenburg, Lieuwe de Haan, Lauren Smith, et al.
Schizophrenia Research|March 18, 2023
Long-term effects of Roluperidone on negative symptoms of schizophreniaJonathan Rabinowitz, Corinne Staner, Jay Saoud, et al.
Frontiers in Aging Neuroscience|June 18, 2025
Neurobiological and therapeutic landmarks of depression associated with Alzheimer's disease dementiaIlinca Untu, Michael Davidson, Gabriela-Dumitrita Stanciu, et al.
Schizophrenia Research|July 3, 2013
Negative symptoms in schizophrenia--the remarkable impact of inclusion definitions in clinical trials and their consequencesJonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, et al.
Journal of Clinical and Experimental Neuropsychology|February 18, 2006
Premorbid intellectual functioning and risk of schizophrenia and spectrum disordersAbraham Reichenberg, Mark Weiser, Asaf Caspi, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|March 24, 2004
Correlates of cognitive deficits in first episode schizophreniaGitry Heydebrand, Marc Weiser, Jonathan Rabinowitz, et al.
The American Journal of Psychiatry|November 27, 2002
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorderAbraham Reichenberg, Mark Weiser, Jonathan Rabinowitz, et al.
Neurology|September 8, 2019
Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trialLon S Schneider, Yona Geffen, Jonathan Rabinowitz, et al.
Schizophrenia Research|November 25, 2003
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episodeAsaf Caspi, Abraham Reichenberg, Mark Weiser, et al.
Schizophrenia Bulletin|May 23, 2008
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disordersAbraham Reichenberg, Philip D Harvey, Christopher R Bowie, et al.
Early Intervention in Psychiatry|January 17, 2020
Early predictors of mental health in mid-adulthoodLisa J Pijnenburg, Lieuwe de Haan, Lauren Smith, et al.
Schizophrenia Research|March 18, 2023
Long-term effects of Roluperidone on negative symptoms of schizophreniaJonathan Rabinowitz, Corinne Staner, Jay Saoud, et al.
Frontiers in Aging Neuroscience|June 18, 2025
Neurobiological and therapeutic landmarks of depression associated with Alzheimer's disease dementiaIlinca Untu, Michael Davidson, Gabriela-Dumitrita Stanciu, et al.
Schizophrenia Research|July 3, 2013
Negative symptoms in schizophrenia--the remarkable impact of inclusion definitions in clinical trials and their consequencesJonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, et al.
Journal of Clinical and Experimental Neuropsychology|February 18, 2006
Premorbid intellectual functioning and risk of schizophrenia and spectrum disordersAbraham Reichenberg, Mark Weiser, Asaf Caspi, et al.
Pageof 11